26
May
This article is an installment of Future Explored, a weekly guide to world-changing technology. You can get stories like this one straight to your inbox by subscribing here.If the COVID-19 vaccines were the most significant FDA approvals of the 2020s so far, GLP-1 agonists to treat obesity are a strong runner up.Though these drugs have been used to treat type 2 diabetes for nearly two decades, it wasn’t until 2021 that the FDA approved one of them — Novo Nordisk’s Wegovy (semaglutide) — as a treatment for obesity. Clinical trials showed that people lost 10-20% of their body weight.This was huge.…